Skip to main content

Study Supports the Need for Real-World Evidence to Better Manage CLL Patients

December 09, 2020

anthony matoAnthony Mato, MD, Memorial Sloan Kettering Cancer Center, discusses prognostic biomarker testing, treatment practices, and outcomes among patients with chronic lymphocytic leukemia (CLL) in the clinical practice setting, using the informCLL prospective registry.


Back to Top